Open AccessReal-world treatment attrition rates in advanced esophagogastric cancer
Author(s) -
Erica S. Tsang,
Howard John Lim,
Daniel J. Renouf,
Janine Marie Davies,
Jonathan M. Loree,
Sharlene Gill
Publication year - 2020
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v26.i39.6027
Subject(s) - esophagogastric junction , medicine , cancer , attrition , gastroenterology , oncology , adenocarcinoma , dentistry
Over the last decade, multiple agents have demonstrated efficacy for advanced esophagogastric cancer (EGC). Despite the availability of later lines of therapy, there remains limited real-world data about the treatment attrition rates between lines of therapy.